Imaging of cells immunoreactive with polyclonal anti-PS100 antibody in a human liver section invaded by metastatic melanoma

Imaging of cells immunoreactive with polyclonal anti-PS100 antibody in a human liver section invaded by metastatic melanomaGwendoline Thiery, Mikhail S. Shchepinov, Edwin M. Southern, Anne Audebourg, Virginie Audard Benoit Terris and Ivo G. Gut
Rapid Commun. Mass Spectrom. 2007 , 21, pp 823–829

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-MS) is becoming a popular tool for imaging histological sections. Currently, this technology is used to image naturally occurring molecules. Here we report a novel development for multiplex imaging of candidate proteins. Rather than detecting whatever molecules happen to be present and above the detection threshold in the desorption pixel, we attach photocleavable mass tags to antibodies to target proteins. 'Staining' of histological sections is carried out similarly to common immunohistochemical procedures with chemiluminescent or fluorescent detection using all antibodies of a multiplex simultaneously. Mass tags with discrete masses are released from their respective antibodies by a laser pulse at 355 nm without added matrix. After scanning, mass spectrometry images are created for the mass of each tag. In contrast to fluorescent tags, mass tags do not exhibit mutual quenching. Sections of healthy human pancreatic tissue were imaged to visualize synaptophysin in neuroendocrine cells, and sections from human lymph node and liver invaded by metastatic melanoma to localize the cancer markers PS100 and HMB45 simultaneously. All these proteins are below the detection threshold of direct MALDI-MS imaging. This method is termed TAMSIM for TArgeted multiplex Mass Spectrometry IMaging.

http://dx.doi.org/10.1002/rcm.2895

Categories:

Tags:

No responses yet

Leave a Reply